Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumio Shimada

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of General Medicine|February 16, 2018
Anxiety and depression in general practice outpatients: the long-term change processFumio Shimada, Yoshiyuki Ohira, Yusuke Hirota, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2014
Cranial magnetic resonance imaging and angiography findings in a patient with hyperglycemic hemichorea-hemiballismJunko Nagai, Tsutomu Yamada, Xia Cao, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 29, 2016
How Accurate Are First Visit Diagnoses Using Synchronous Video Visits with Physicians?Mitsuyasu Ohta, Yoshiyuki Ohira, Takanori Uehara, et al.
Diabetes Research and Clinical Practice|September 11, 2003
The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetesMasaaki Ochi, Haruhiko Osawa, Hiroshi Onuma, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 17, 2020
Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled TrialRyoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.
Journal of Diabetes Investigation|July 6, 2020
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of General Medicine|February 16, 2018
Anxiety and depression in general practice outpatients: the long-term change processFumio Shimada, Yoshiyuki Ohira, Yusuke Hirota, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2014
Cranial magnetic resonance imaging and angiography findings in a patient with hyperglycemic hemichorea-hemiballismJunko Nagai, Tsutomu Yamada, Xia Cao, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 29, 2016
How Accurate Are First Visit Diagnoses Using Synchronous Video Visits with Physicians?Mitsuyasu Ohta, Yoshiyuki Ohira, Takanori Uehara, et al.
Diabetes Research and Clinical Practice|September 11, 2003
The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetesMasaaki Ochi, Haruhiko Osawa, Hiroshi Onuma, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 17, 2020
Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled TrialRyoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.
Journal of Diabetes Investigation|July 6, 2020
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study)Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, et al.
Pageof 2